Remove Cardiovascular Disease Remove Heart Attack Remove Innovation
article thumbnail

Allina Health’s Abbott Northwestern Hospital is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure

DAIC

The father of three and grandfather of eight, he has had three heart attacks in the last three years, which led to congestive heart failure. “I We value our collaboration with them and commend their ongoing efforts to advance the treatment of heart failure symptoms.”

article thumbnail

Study Finds AI Can Help Predict Patients With High Risk of Major Adverse Cardiac Events

DAIC

2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heart failure.

article thumbnail

Gujarat’s 2023 Cardiac Crisis! EMRI got 1 call every 7.5 mins

Wellnest

Chirag Doshi’s take on the increasing Cardiac Emergencies in Gujarat Dr. Chirag Doshi, the director of the UN Mehta Institute of Cardiology and Research Centre (UNMICRC), has highlighted the increasing global incidence of cardiovascular diseases, attributing it to lifestyle choices and various risk factors.

article thumbnail

Allina Health Minneapolis Heart Institute is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure

DAIC

The father of three and grandfather of eight, he has had three heart attacks in the last three years, which led to congestive heart failure. “I We value our collaboration with them and commend their ongoing efforts to advance the treatment of heart failure symptoms.”

article thumbnail

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

article thumbnail

Trial Results: Low-Dose Colchicine Helps Treat Cardiovascular Disease

DAIC

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

article thumbnail

Leveraging AI-Enabled Remote Cardiac Monitoring to Improve Cardiovascular Care

DAIC

Imagine a future where a silent, undetected heart condition is caught before it turns into a life-threatening event a future where artificial intelligence (AI) -powered insights alert clinicians to warning signs long before symptoms appear. Cardiovascular disease (CVD) remains the leading cause of death in the U.S.